KW-8232
KW-8232 is an orally bioavailable small molecule developed for osteoporosis research. It functions by inhibiting the biosynthesis of prostaglandin E2 (PGE2) . This mechanism has been investigated in both in vitro assays and in vivo animal models for bone metabolism studies.
Product Specifications
CAS Number
217813-15-5
Field of Research
Immunology & Inflammation, Infectious Disease & Virology, Pharmacology & Drug Discovery
Smiles
CS (O) (=O) =O.CN (C) CCn1c (C (=O) N2CCN (CC2) c2ccccc2Cl) c (C (c2ccc (O) cc2) c2ccc (O) cc2) c2ccccc12
Molecular Formula
C37H41ClN4O6S
Molecular Weight
705.27
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-18288R-PE-Cy5.5 100 µL
LIPC Polyclonal Antibody, PE-Cy5.5 Conjugated
Sign In for Pricing
View Details 
bsm-54150R-BF555-TR 20 µL
Rad51 Recombinant Antibody, AbBy Fluor™ 555 Conjugated
Sign In for Pricing
View Details CMA6206-01 30 µL
Recombinant Anti-PKC delta (Phospho-Y313) Rabbit mAb
Sign In for Pricing
View Details CMA6206-02 50 μL
Recombinant Anti-PKC delta (Phospho-Y313) Rabbit mAb
Sign In for Pricing
View Details